Effect of Dual-Task Training on Pediatric Oncology Patients

Sponsor
Afyonkarahisar Health Sciences University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05118464
Collaborator
(none)
21
1
1
24
0.9

Study Details

Study Description

Brief Summary

It is known that the treatment of children with cancer has negative effects on cognition, muscle strength, balance, and gait. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait.

Condition or Disease Intervention/Treatment Phase
  • Other: Dual-task training
N/A

Detailed Description

With the increase in the incidence of cancer, the number of children who survived cancer is also increasing. Most studies on cancer survivors show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, motor, and cognitive skills. Therefore, the aim of this study is to evaluate the effects of dual-task training, which is based on the principle of simultaneous performance of cognitive tasks and motor tasks, on muscle strength, balance, and gait. This study is planned to be the first study in which dual-task training is applied in children with cancer.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
21 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Evaluation of the Effect of Dual-Task Training on Muscle Strength, Balance, and Gait in Pediatric Oncology Patients
Actual Study Start Date :
Sep 15, 2021
Anticipated Primary Completion Date :
Sep 15, 2022
Anticipated Study Completion Date :
Sep 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Children with cancer

The arm of the research will consist of pediatric patients aged 6-18 years who have been diagnosed with cancer in Afyonkarahisar Health Sciences University, Health Application and Research Center, Department of Pediatric Hematology-Oncology Clinics and who come for outpatient treatment.

Other: Dual-task training
Dual-task training includes simultaneous execution of motor and cognitive tasks. The motor tasks in this study will be walking, going up and downstairs, turning, throwing, and holding a ball. Cognitive tasks will be an n-back test, verbal fluency, remembering sequences of numbers, and performing simple summing.

Outcome Measures

Primary Outcome Measures

  1. gait speed [600 seconds]

    Gait speed is the time one takes to walk a specified distance on level surfaces over a short distance. It will be recorded in m/s.

  2. balance [300 seconds]

    Balance is evaluated with Timed-up and Go Test. The time elapsed during the test is recorded in seconds.

  3. Muscle strength [600 seconds]

    Isometric muscle strength will be evaluated with a hand-held dynamometer. It will be recorded in kg.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosed with pediatric cancer and inpatient and outpatient treatment in Hematology-Oncology Clinics for treatment,

  • Able to walk alone without any walking aid,

  • Children aged 6-18 will be included

Exclusion Criteria:
  • Staying in an isolated room or at risk of infection (neutropenic, etc.),

  • Any orthopedic or neurological disorder that may prevent walking;

  • Having any mental disability that will prevent performing a cognitive task,

  • Individuals with malignant hypertension or unstable heart disease (eg, congestive heart failure) will not be included in the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Emel Taşvuran Horata Afyonkarahisar Turkey 03030

Sponsors and Collaborators

  • Afyonkarahisar Health Sciences University

Investigators

  • Principal Investigator: EMEL TAŞVURAN HORATA, PhD, AFSU

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Emel Taşvuran Horata, PhD; Assistant Professor, Afyonkarahisar Health Sciences University
ClinicalTrials.gov Identifier:
NCT05118464
Other Study ID Numbers:
  • 2020/387
First Posted:
Nov 12, 2021
Last Update Posted:
Nov 12, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Emel Taşvuran Horata, PhD; Assistant Professor, Afyonkarahisar Health Sciences University

Study Results

No Results Posted as of Nov 12, 2021